Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled study of SPT-07A injection in acute ischemic stroke
CTR20212911Phase 3Active
- Sponsor
- Suzhou Huyun Oncology Research Center
- Start
- Jan 2022
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of d-borneol in ischemic stroke, sponsored by Suzhou Huyun Oncology Research Center. Started Jan 2022; status: active.
02
Drugs
d-borneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20212911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212911.